GlassScriptPhysician profile
Jacob Minor
NPI 1033613930
$3,715.56
in general payments reported to CMS, 2019-2025
11 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,786 · 2024: $1,792 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762 · Travel and Lodging: $1,194 · Education: $750 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.38 |
| Travel and Lodging | $1,194.44 |
| Education | $750.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,651.68 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $396.66 | 2023-2024 | Spyglass Discover, Spyglass |
| Integra Lifesciences Corporation | $214.93 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Kerecis Limited | $144.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bone Support INC. | $129.14 | 2024 | Ceramentbone Void Filler, Cerament G |
| Stryker Corporation | $71.43 | 2024 | 1788 |
| Genzyme Corporation | $37.38 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $23.11 | 2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $17.95 | 2025 | Voquezna |
| W. L. Gore & Associates, INC. | $15.29 | 2025 | Gore Synecor Biomaterial |
| Janssen Pharmaceuticals, INC | $13.17 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Minor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.